Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile (Q39531759)
Jump to navigation
Jump to search
scientific article published on 16 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile |
scientific article published on 16 June 2011 |
Statements
1 reference
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile (English)
1 reference
Haishan Wang
1 reference
Niefang Yu
1 reference
Dizhong Chen
1 reference
Ken Chi Lik Lee
1 reference
Pek Ling Lye
1 reference
Joyce Wei Wei Chang
1 reference
Weiping Deng
1 reference
Melvin Chi Yeh Ng
1 reference
Ting Lu
1 reference
Mui Ling Khoo
1 reference
Anders Poulsen
1 reference
Kanda Sangthongpitag
1 reference
Xiaofeng Wu
1 reference
Changyong Hu
1 reference
Kee Chuan Goh
1 reference
Xukun Wang
1 reference
Lijuan Fang
1 reference
Kay Lin Goh
1 reference
Hwee Hoon Khng
1 reference
Siok Kun Goh
1 reference
Pauline Yeo
1 reference
Xin Liu
1 reference
Zahid Bonday
1 reference
Jeanette M Wood
1 reference
Brian W Dymock
1 reference
Ethirajulu Kantharaj
1 reference
Eric T Sun
1 reference
16 June 2011
1 reference
1 reference
4694-4720
1 reference
Identifiers
1 reference